Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

RIFAMPIN Drug Profile

« Back to Dashboard

What is the patent landscape for Rifampin, and what generic alternatives are available?

Rifampin is a drug marketed by Emcure Pharms Ltd, Akorn, West-ward Pharms Int, Mylan Labs Ltd, Lupin Pharms, Watson Pharms Teva, Hikma Pharms, Sandoz, Fresenius Kabi Usa, Lannett, and Hikma Intl Pharms. and is included in twelve NDAs.

The generic ingredient in RIFAMPIN is isoniazid; rifampin. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the isoniazid; rifampin profile page.

Summary for Tradename: RIFAMPIN

Patents:0
Applicants:11
NDAs:12
Suppliers / Packagers: see list26
Bulk Api Vendors: see list59
Clinical Trials: see list74
Patent Applications: see list8,354
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIFAMPIN at DailyMed

Pharmacology for Tradename: RIFAMPIN

Ingredient-typeRifamycins
Drug ClassRifamycin Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd
RIFAMPIN
rifampin
INJECTABLE;INJECTION204101-001Aug 18, 2014APRXNoNo► Subscribe► Subscribe
Lupin Pharms
RIFAMPIN
rifampin
CAPSULE;ORAL090034-001Aug 21, 2013ABRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
RIFAMPIN
rifampin
INJECTABLE;INJECTION065421-001May 22, 2008APRXNoNo► Subscribe► Subscribe
Sandoz
RIFAMPIN
rifampin
CAPSULE;ORAL064150-001May 28, 1997ABRXNoNo► Subscribe► Subscribe
Lupin Pharms
RIFAMPIN
rifampin
CAPSULE;ORAL090034-002Aug 21, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot